1. Home
  2. IRWD vs ELVA Comparison

IRWD vs ELVA Comparison

Compare IRWD & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • ELVA
  • Stock Information
  • Founded
  • IRWD 1998
  • ELVA 1996
  • Country
  • IRWD United States
  • ELVA Canada
  • Employees
  • IRWD N/A
  • ELVA N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • ELVA
  • Sector
  • IRWD Health Care
  • ELVA
  • Exchange
  • IRWD Nasdaq
  • ELVA Nasdaq
  • Market Cap
  • IRWD 111.2M
  • ELVA 125.5M
  • IPO Year
  • IRWD 2010
  • ELVA N/A
  • Fundamental
  • Price
  • IRWD $1.13
  • ELVA $5.87
  • Analyst Decision
  • IRWD Buy
  • ELVA Strong Buy
  • Analyst Count
  • IRWD 5
  • ELVA 4
  • Target Price
  • IRWD $4.94
  • ELVA $6.13
  • AVG Volume (30 Days)
  • IRWD 1.4M
  • ELVA 440.6K
  • Earning Date
  • IRWD 11-06-2025
  • ELVA 08-13-2025
  • Dividend Yield
  • IRWD N/A
  • ELVA N/A
  • EPS Growth
  • IRWD N/A
  • ELVA 58.59
  • EPS
  • IRWD N/A
  • ELVA 0.03
  • Revenue
  • IRWD $308,519,000.00
  • ELVA $54,875,000.00
  • Revenue This Year
  • IRWD N/A
  • ELVA $46.69
  • Revenue Next Year
  • IRWD N/A
  • ELVA $51.84
  • P/E Ratio
  • IRWD N/A
  • ELVA $215.26
  • Revenue Growth
  • IRWD N/A
  • ELVA 10.88
  • 52 Week Low
  • IRWD $0.53
  • ELVA $1.73
  • 52 Week High
  • IRWD $5.13
  • ELVA $6.70
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 52.75
  • ELVA 61.12
  • Support Level
  • IRWD $1.01
  • ELVA $5.71
  • Resistance Level
  • IRWD $1.35
  • ELVA $6.70
  • Average True Range (ATR)
  • IRWD 0.10
  • ELVA 0.42
  • MACD
  • IRWD -0.02
  • ELVA 0.06
  • Stochastic Oscillator
  • IRWD 33.33
  • ELVA 64.13

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About ELVA Electrovaya Inc.

Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.

Share on Social Networks: